Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]
Deferred offering costs	$ 300,000
Other income, net	6,715,000	$ 1,490,000
Interest income	7,000,000	1,500,000
Leasehold improvements		0
Impairment losses on long lived assets	0	0
Research and development expense	46,024,000	23,949,000
Foreign currency transaction gains (losses)	100,000	0
Unrecognized tax benefits	$ 0	0
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 01, 2023
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]	true
Accounting Standards Update [Extensible Enumeration]	us-gaap:AccountingStandardsUpdate201613Member
Lilly Agreement
Summary of Significant Accounting Policies [Line Items]
Research and development expense	$ 0	$ 0